These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15192318)
1. Magical ideation -- defense mechanism or neuropathology? A study with multiple sclerosis patients. te Wildt BT; Schultz-Venrath U Psychopathology; 2004; 37(3):141-4. PubMed ID: 15192318 [TBL] [Abstract][Full Text] [Related]
2. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429 [TBL] [Abstract][Full Text] [Related]
3. The presence of magical thinking in obsessive compulsive disorder. Einstein DA; Menzies RG Behav Res Ther; 2004 May; 42(5):539-49. PubMed ID: 15033500 [TBL] [Abstract][Full Text] [Related]
4. Magical ideation, creativity, handedness, and cerebral asymmetries: a combined behavioural and fMRI study. Badzakova-Trajkov G; Häberling IS; Corballis MC Neuropsychologia; 2011 Aug; 49(10):2896-903. PubMed ID: 21722656 [TBL] [Abstract][Full Text] [Related]
5. Does magical thinking produce neutralising behaviour? An experimental investigation. Bocci L; Gordon PK Behav Res Ther; 2007 Aug; 45(8):1823-33. PubMed ID: 17403518 [TBL] [Abstract][Full Text] [Related]
6. Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Arnett PA; Higginson CI; Voss WD; Randolph JJ; Grandey AA Clin Neuropsychol; 2002 Aug; 16(3):341-55. PubMed ID: 12607147 [TBL] [Abstract][Full Text] [Related]
7. Magical ideation associated social cognition in adolescents: signs of a negative facial affect recognition deficit. Canli D; Ozdemir H; Kocak OM Compr Psychiatry; 2015 Aug; 61():90-6. PubMed ID: 26073064 [TBL] [Abstract][Full Text] [Related]
8. Magical thinking in obsessive-compulsive disorder and generalized anxiety disorder. West B; Willner P Behav Cogn Psychother; 2011 Jul; 39(4):399-411. PubMed ID: 21333031 [TBL] [Abstract][Full Text] [Related]
9. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis. Kern S; Schrempf W; Schneider H; Schultheiss T; Reichmann H; Ziemssen T Mult Scler; 2009 Jun; 15(6):752-8. PubMed ID: 19482864 [TBL] [Abstract][Full Text] [Related]
10. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis. Haase CG; Tinnefeld M; Faustmann PM Neuroimmunomodulation; 2004; 11(6):365-72. PubMed ID: 15467351 [TBL] [Abstract][Full Text] [Related]
11. Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. Goretti B; Portaccio E; Zipoli V; Razzolini L; Amato MP Neurol Sci; 2010 Nov; 31(Suppl 2):S227-30. PubMed ID: 20640468 [TBL] [Abstract][Full Text] [Related]
13. Role of magical thinking in obsessive-compulsive symptoms in an undergraduate sample. Einstein DA; Menzies RG Depress Anxiety; 2004; 19(3):174-9. PubMed ID: 15129419 [TBL] [Abstract][Full Text] [Related]
14. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589 [TBL] [Abstract][Full Text] [Related]
15. Coping with infertility: a new nursing perspective. Bernstein J; Brill M; Levin S; Seibel M NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(2):335-42. PubMed ID: 1375835 [TBL] [Abstract][Full Text] [Related]
16. [Coping style and cognitive attitude in patients with multiple sclerosis]. Lasar M; Kotterba S Wien Klin Wochenschr; 1997 Dec; 109(24):954-9. PubMed ID: 9491539 [TBL] [Abstract][Full Text] [Related]
17. Magical ideation is related to questionnaire but not behavioural measures of handedness. Grimshaw GM; Yelle SK; Schoger J; Bright KS Laterality; 2008 Jan; 13(1):22-33. PubMed ID: 17891681 [TBL] [Abstract][Full Text] [Related]
18. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501 [TBL] [Abstract][Full Text] [Related]
19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]